This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant drugs are used in increasing numbers. This report also provides new evidence that drugs for erectile dysfunction and pulmonary arterial hypertension can cause deafness or sudden hearing loss.
To read this article, please click here.
More RSI News
Decision making framework developed for Canadian Blood Services (CBS) now online
RSI was contracted by CBS to assist the Alliance of Blood Operators in the development of a blood-safety oriented risk-based decision-making framework. Why use this…
RSI speaks to The Weather Network about wildfires and climate
2017 was a record-setting year for devastating wildfires across Canada and throughout the world. The Weather Network spoke to Heather Auld, principal climate scientist about…
RSI paper on Manganese PBPK selected as a top 2017 paper
Each year the Society of Toxicology, Biological Modeling Specialty Section (BMSS) does a literature search to identify outstanding modeling papers in the field of toxicology.…
RSI and Engineers Canada develop on-line training courses
Engineers Canada has retained Risk Sciences International’s (RSI) Climate Group to develop training course modules and to deliver on-line training to Professional Engineers seeking to…